GSA Capital Partners LLP Makes New $1.13 Million Investment in LifeStance Health Group, Inc. (NASDAQ:LFST)

GSA Capital Partners LLP bought a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 170,043 shares of the company's stock, valued at approximately $1,132,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. DekaBank Deutsche Girozentrale acquired a new position in LifeStance Health Group in the 1st quarter valued at $31,000. Xponance Inc. acquired a new position in LifeStance Health Group during the first quarter worth about $69,000. Ameriprise Financial Inc. acquired a new position in LifeStance Health Group during the fourth quarter worth about $87,000. Kapitalo Investimentos Ltda purchased a new stake in LifeStance Health Group during the 1st quarter valued at about $87,000. Finally, Forum Financial Management LP acquired a new stake in LifeStance Health Group in the 4th quarter valued at about $110,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the transaction, the insider owned 113,435 shares of the company's stock, valued at approximately $673,803.90. This trade represents a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 6.60% of the stock is currently owned by corporate insiders.

LifeStance Health Group Stock Performance

Shares of NASDAQ:LFST traded up $0.09 during trading on Monday, reaching $3.88. The company had a trading volume of 570,278 shares, compared to its average volume of 1,845,075. LifeStance Health Group, Inc. has a fifty-two week low of $3.74 and a fifty-two week high of $8.61. The stock's fifty day moving average price is $4.96 and its 200 day moving average price is $6.31. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of -38.76 and a beta of 1.13. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.47 and a quick ratio of 1.47.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on LFST. UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price for the company in a research note on Tuesday, May 27th. KeyCorp initiated coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target for the company. Finally, BTIG Research assumed coverage on shares of LifeStance Health Group in a research note on Friday, July 25th. They set a "buy" rating and a $8.00 target price for the company. One investment analyst has rated the stock with a sell rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $8.42.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.